HIT! High Impact Clinical Trials 1

28 Mar 2026 3:45 p.m. 4:45 p.m.

Main Hall

Sydney Tang Chair Hong Kong, China

Time	Session

3:45 p.m. 3:55 p.m.	Remodel Overview - Framework And Key Outcomes PetterBjornstad Speaker United States
3:55 p.m. 4:05 p.m.	Semaglutide Improves Kidney Outcomes Regardless Of SGLT2i Use In People With Chronic Kidney Disease And Type 2 Diabetes: Post-hoc Analysis The Remodel Trial DavidCherney Speaker Canada
4:05 p.m. 4:15 p.m.	ACHIEVE
4:15 p.m. 4:25 p.m.	Prepare For Kidney Care: Preparing For Responsive Management Versus Preparing For Renal Dialysis In Multimorbid Frail Older People With Chronic Kidney Disease FergusCaskey Speaker United Kingdom
4:25 p.m. 4:35 p.m.	B-cell Targeted Therapy for Idiopathic Nephrotic Syndrome: Results of the Phase III Global Multicenter Inshore Trial Evaluating Efficacy and Safety of Obinutuzumab vs Mycophenolate Mofetil JulienHogan Speaker France